• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

CVS Uses Analytics to Expand Transform Diabetes Care Program

by Fred Pennic 07/31/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

CVS Uses Analytics to Expand Transform Diabetes Care Program

More than two years since its launch, pharmacy benefit manager (PBM) CVS Caremark’s Transform Diabetes Care program has helped PBM members better control their diabetes through a combination of highly personalized member support and coaching focused on improving medication adherence and better control of HbA1c. In fact, more than 50 percent of members with uncontrolled diabetes who enrolled in the program have moved to a controlled status and, on average, members have improved HbA1c by 1.2 percentage points. 

Transform Diabetes Care Program Expansion Details

Building on this success, CVS Caremark is announcing an expansion of its Transform Diabetes Care program to focus on prevention and early identification of diabetes, as well as the launch of a new program, focused on hypertension, a common comorbidity of diabetes. Both use an advanced analytics engine (pharmacy, medical and lab data) to identify and enroll members who may have pre-diabetes and those who have hypertension.

Expanding Transform Diabetes Care to also focus on prevention

About 34 percent of adults have prediabetes, and approximately 90 percent of prediabetics don’t know they have it. CVS Caremark’s analytics engine will analyze pharmacy and medical data to identify those at risk for developing diabetes and intervene with a lifestyle-focused program. As part of that, eligible members will receive connected digital scale, a CDC-approved app-driven prevention program and health coaching with experts across a range of specialties (nurses, dieticians, exercise, behavioral). Members also can engage with practitioners at CVS Minute Clinics – offering a 360-degree member-centric approach to care coordination. The overall goal is to help reduce incidence of diabetes in a given population by 58 percent in three years.

New focus on hypertension

Given that hypertension is twice as frequent in diabetes patients, CVS Caremark will use its analytics engine to identify and intervene with members enrolled in Transform Diabetes Care who also have hypertension, through its new Transform Hypertension Care program. These members will receive a connected blood-pressure cuff, which will automatically capture blood pressure readings and store them in a secure, personal profile; an app-based hypertension management program including digital coaching, weekly challenges, and education; as well as access to specialized experts on demand for personalized condition management and support. In addition, members can access two annual metabolic visits at MinuteClinic with no out-of-pocket cost including screenings, education, targeted physical exams, and treatment initiation as needed, to help prevent the onset of complications.

CVS Health’ Continued Investment in Diabetes Care

The U.S. health care system traditionally has focused on treating people who already have chronic conditions given the high costs if not managed appropriately.  However, now, payers are looking more and more at prevention to head off high costs associated with chronic conditions such as diabetes. That’s why CVS Health continues to invest in programs across their enterprise that focus on enhancing clinical outcomes and lowering costs, such as this expanded Transform Diabetes Care and new Transform Hypertension Care program. Transform Diabetes Care demonstrates that CVS is moving to integrate the latest innovations in digital health, connected devices and one-on-one, high-touch personalized support.

For more information on the CVS Transform Diabetes Care Program, click here. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Blood Pressure, Care Coordination, CVS Health, diabetes, digital health, Hypertension, medication, Medication Adherence, Payers, Pharmacy, risk

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |